Xiaoling Liu

2.1k total citations
95 papers, 1.6k citations indexed

About

Xiaoling Liu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaoling Liu has authored 95 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 26 papers in Immunology and 18 papers in Cancer Research. Recurrent topics in Xiaoling Liu's work include Atherosclerosis and Cardiovascular Diseases (7 papers), Cancer-related molecular mechanisms research (7 papers) and Atomic and Subatomic Physics Research (6 papers). Xiaoling Liu is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (7 papers), Cancer-related molecular mechanisms research (7 papers) and Atomic and Subatomic Physics Research (6 papers). Xiaoling Liu collaborates with scholars based in China, United States and Hong Kong. Xiaoling Liu's co-authors include Jun‐Wu Zhang, Guomin Shen, Fenglin Zhang, Wenjun Liu, Lei Sun, Zhendong Zhao, Yingze Zhao, Yuhai Bi, Ke Zhang and Chong‐Feng Xu and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Xiaoling Liu

86 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Liu China 24 788 439 329 292 131 95 1.6k
Pelagia Foka Greece 17 949 1.2× 340 0.8× 252 0.8× 316 1.1× 179 1.4× 35 1.9k
Spiros Vlahopoulos Greece 23 1.1k 1.4× 304 0.7× 347 1.1× 227 0.8× 111 0.8× 59 1.8k
Lina Zhang China 15 625 0.8× 878 2.0× 219 0.7× 342 1.2× 140 1.1× 48 1.6k
Can Cui China 24 958 1.2× 595 1.4× 356 1.1× 284 1.0× 108 0.8× 91 2.1k
Zhonghan Yang China 28 836 1.1× 441 1.0× 317 1.0× 214 0.7× 66 0.5× 70 1.9k
Ruijie Liu Australia 23 909 1.2× 592 1.3× 185 0.6× 181 0.6× 245 1.9× 44 2.0k
Yansheng Feng China 18 1.0k 1.3× 152 0.3× 302 0.9× 216 0.7× 89 0.7× 38 1.7k
Liping Liu China 25 1.4k 1.7× 229 0.5× 650 2.0× 396 1.4× 126 1.0× 50 2.2k
Yasuyuki Kitaura Japan 24 1.2k 1.5× 286 0.7× 323 1.0× 179 0.6× 135 1.0× 62 2.0k

Countries citing papers authored by Xiaoling Liu

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Liu more than expected).

Fields of papers citing papers by Xiaoling Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Liu. The network helps show where Xiaoling Liu may publish in the future.

Co-authorship network of co-authors of Xiaoling Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Liu. A scholar is included among the top collaborators of Xiaoling Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Liu. Xiaoling Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Pei‐Chi, Xiaoling Liu, Wen‐Shuo Kuo, et al.. (2025). Exosomal MicroRNA let-7 Modulates Lipid Metabolism and Inflammation in Foamy Macrophages of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences. 26(18). 8800–8800.
2.
Chen, Pei‐Chi, Yu‐Lung Hsu, Xiaoling Liu, et al.. (2025). Anti-nucleocapsid antibody levels reflect post-acute sequelae of COVID-19 symptom burden in children. Journal of Infection and Public Health. 19(1). 103020–103020.
3.
Liu, Xiaoling, et al.. (2025). Application Value of A Clinical Radiomic Nomogram for Identifying Diabetic Nephropathy and Nondiabetic Renal Disease. Current Medical Imaging Formerly Current Medical Imaging Reviews. 21. e15734056332507–e15734056332507.
4.
Liu, Xiaoling, et al.. (2025). Machine Learning Model for Risk Stratification of Papillary Thyroid Carcinoma Based on Radiopathomics. Academic Radiology. 32(5). 2545–2553. 1 indexed citations
5.
Ma, Hong, Lijie Yao, Xuelian Pang, et al.. (2024). High glucose levels accelerate atherosclerosis via NLRP3-IL/ MAPK/NF-κB-related inflammation pathways. Biochemical and Biophysical Research Communications. 704. 149702–149702. 5 indexed citations
6.
Zhang, Ming, Haidong Li, Yi Xiao, et al.. (2024). Assessment of Global and Regional Lung Compliance in Pulmonary Fibrosis With Hyperpolarized Gas MRI. Journal of Magnetic Resonance Imaging. 61(3). 1404–1415. 1 indexed citations
7.
Liu, Xiaoling, et al.. (2024). Measurement of pulmonary hematocrit using oscillation of hyperpolarized 129Xe MR signals in blood. Magnetic Resonance in Medicine. 93(5). 1886–1895. 3 indexed citations
8.
Lu, Jingyu, Wen Ding, Liping Zhang, & Xiaoling Liu. (2023). A nomogram for predicting mild cognitive impairment in older adults with hypertension. BMC Neurology. 23(1). 363–363. 6 indexed citations
9.
Tan, Huiwen, Li Wang, Yanli Cheng, et al.. (2021). Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes. PLoS ONE. 16(1). e0243938–e0243938. 15 indexed citations
10.
Zhou, Danni, Ying Tan, Xiaoling Liu, et al.. (2021). Patient-specific iPSC-derived endothelial cells reveal aberrant p38 MAPK signaling in atypical hemolytic uremic syndrome. Stem Cell Reports. 16(9). 2305–2319. 9 indexed citations
12.
Nian, Yin, Nihong Lu, Xiaoling Liu, et al.. (2018). Antiacetylcholinesterase triterpenes from the fruits of Cimicifuga yunnanensis. RSC Advances. 8(14). 7832–7838. 6 indexed citations
13.
Wen, Hao, Minghao Liu, Zhaoqiang Liu, et al.. (2017). PEDF improves atherosclerotic plaque stability by inhibiting macrophage inflammation response. International Journal of Cardiology. 235. 37–41. 35 indexed citations
14.
Zhu, Gaizhi, Xiaoqian Wang, Xiao He, et al.. (2017). Both Notch1 and its ligands in B cells promote antibody production. Molecular Immunology. 91. 17–23. 20 indexed citations
15.
Wang, Shanshan, Alexander C. Vlantis, Enders K. Ng, et al.. (2016). Expression of Antioxidant Molecules and Heat Shock Protein 27 in Thyroid Tumors. Journal of Cellular Biochemistry. 117(11). 2473–2481. 17 indexed citations
16.
Liu, Xiaoling, Mengyun Hu, Yi Zhang, et al.. (2015). Sequence-dependent abnormal aggregation of human Tau fragment in an inducible cell model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(8). 1561–1573. 13 indexed citations
17.
Xue, Qinghua, Limin Yang, Xiaoling Liu, & Wenjun Liu. (2009). Molecular Characterization of Feline Type I Interferon Receptor 2. Journal of Interferon & Cytokine Research. 30(2). 81–88. 6 indexed citations
18.
Feng, Min, Xiaojun Cai, Wei Zhang, et al.. (2009). Interleukin‐6 enhances matrix metalloproteinase‐14 expression via the RAF–mitogen‐activated protein kinase kinase–extracellular signal‐regulated kinase 1/2–activator protein‐1 pathway. Clinical and Experimental Pharmacology and Physiology. 37(2). 162–166. 6 indexed citations
19.
Liu, Xiaoling. (2002). Inhibitive Effects of Sinomenine on Inflammatory Synovium in Rats with Arthritis Induced by Collagen II and Its Mechanism. Guangzhou Zhongyiyao Daxue xuebao. 2 indexed citations
20.
Liu, Xiaoling, et al.. (1993). Erteng Tongbi Mixture for the Treatment of Rheumatoid Arthritis: An Clinical Observation of 162 Cases. Traditional Chinese Drug Research and Clinical Pharmacology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026